Ad is loading...
OGEN
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
SRPT
Price
$110.50
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

OGEN vs SRPT

Header iconOGEN vs SRPT Comparison
Open Charts OGEN vs SRPTBanner chart's image
Oragenics
Price$0.27
Change-$0.00 (-0.00%)
Volume$406.65K
CapitalizationN/A
Sarepta Therapeutics
Price$110.50
Change-$0.00 (-0.00%)
Volume$917.37K
CapitalizationN/A
OGEN vs SRPT Comparison Chart
Loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
OGEN vs. SRPT commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGEN is a Hold and SRPT is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (OGEN: $0.27 vs. SRPT: $114.23)
Brand notoriety: OGEN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OGEN: 41% vs. SRPT: 96%
Market capitalization -- OGEN: $3.35M vs. SRPT: $10.91B
OGEN [@Biotechnology] is valued at $3.35M. SRPT’s [@Biotechnology] market capitalization is $10.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGEN’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • OGEN’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, OGEN is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGEN’s TA Score shows that 2 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • OGEN’s TA Score: 2 bullish, 4 bearish.
  • SRPT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than OGEN.

Price Growth

OGEN (@Biotechnology) experienced а -14.56% price change this week, while SRPT (@Biotechnology) price change was +9.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

OGEN is expected to report earnings on May 15, 2023.

SRPT is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($10.9B) has a higher market cap than OGEN($3.35M). SRPT YTD gains are higher at: 14.591 vs. OGEN (-95.190). SRPT has higher annual earnings (EBITDA): 187M vs. OGEN (-19.94M). SRPT has more cash in the bank: 1.2B vs. OGEN (3.14M). OGEN has less debt than SRPT: OGEN (519K) vs SRPT (1.4B). SRPT has higher revenues than OGEN: SRPT (1.64B) vs OGEN (0).
OGENSRPTOGEN / SRPT
Capitalization3.35M10.9B0%
EBITDA-19.94M187M-11%
Gain YTD-95.19014.591-652%
P/E RatioN/A74.18-
Revenue01.64B-
Total Cash3.14M1.2B0%
Total Debt519K1.4B0%
FUNDAMENTALS RATINGS
OGEN vs SRPT: Fundamental Ratings
OGEN
SRPT
OUTLOOK RATING
1..100
5563
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
10061
PRICE GROWTH RATING
1..100
9662
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGEN's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for SRPT (82). This means that OGEN’s stock grew somewhat faster than SRPT’s over the last 12 months.

SRPT's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as OGEN (100). This means that SRPT’s stock grew similarly to OGEN’s over the last 12 months.

SRPT's SMR Rating (61) in the Biotechnology industry is somewhat better than the same rating for OGEN (100). This means that SRPT’s stock grew somewhat faster than OGEN’s over the last 12 months.

SRPT's Price Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for OGEN (96). This means that SRPT’s stock grew somewhat faster than OGEN’s over the last 12 months.

SRPT's P/E Growth Rating (99) in the Biotechnology industry is in the same range as OGEN (100). This means that SRPT’s stock grew similarly to OGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OGENSRPT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
OGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HIGH23.650.08
+0.34%
Simplify Enhanced Income ETF
IBDW20.53N/A
N/A
iShares iBonds Dec 2031 Term Corp ETF
MUB107.54-0.05
-0.05%
iShares National Muni Bond ETF
PBP23.01-0.02
-0.09%
Invesco S&P 500 BuyWrite ETF
FRNW14.04-0.03
-0.19%
Fidelity Clean Energy ETF

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-6.04%
ATHA - OGEN
34%
Loosely correlated
+2.62%
SRPT - OGEN
30%
Poorly correlated
-0.32%
CHRS - OGEN
27%
Poorly correlated
N/A
RNA - OGEN
26%
Poorly correlated
-2.50%
FBRX - OGEN
25%
Poorly correlated
+15.42%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with TECX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
-0.32%
TECX - SRPT
56%
Loosely correlated
+1.95%
GLMD - SRPT
51%
Loosely correlated
-5.41%
ALZN - SRPT
49%
Loosely correlated
-0.76%
XBIO - SRPT
48%
Loosely correlated
+0.57%
BMRN - SRPT
45%
Loosely correlated
+1.42%
More